105 related articles for article (PubMed ID: 30158413)
21. [Evaluation of subselective intraarterial infusion chemotherapy in far advanced gastric and colorectal cancer].
Murotani M; Takami M; Fujimoto T; Takada T; Kitada M; Tsukahara Y; Okumura Y; Saito M; Shibata T; Watanabe Y
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1650-3. PubMed ID: 8373239
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
Nukatsuka M; Nakagawa F; Takechi T
Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
[TBL] [Abstract][Full Text] [Related]
23. [Combination therapy including mutamycin (mitomycin C) in the treatment of advanced colorectal and gastric cancer].
Manziuk LV; Artamonova EV; Sholokhov VN; Strygina EA
Vopr Onkol; 2001; 47(6):736-9. PubMed ID: 11826500
[TBL] [Abstract][Full Text] [Related]
24. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; Fruth B; Meyerhardt JA; Schrag D; Greene C; O'Neil BH; Atkins JN; Berry S; Polite BN; O'Reilly EM; Goldberg RM; Hochster HS; Schilsky RL; Bertagnolli MM; El-Khoueiry AB; Watson P; Benson AB; Mulkerin DL; Mayer RJ; Blanke C
JAMA; 2017 Jun; 317(23):2392-2401. PubMed ID: 28632865
[TBL] [Abstract][Full Text] [Related]
25. High-dose infusional 5-fluorouracil combination therapy of metastatic gastric and colorectal cancer.
Loeffler TM; Hausamen TU
J Infus Chemother; 1996; 6(3):137-40. PubMed ID: 9229325
[TBL] [Abstract][Full Text] [Related]
26. Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer.
Montemurro F; Mittica G; Cagnazzo C; Longo V; Berchialla P; Solinas G; Culotta P; Martinello R; Foresto M; Gallizioli S; Calori A; Grasso B; Volpone C; Bertola G; Parola G; Tealdi G; Giuliano PL; Aglietta M; Ballari AM
JAMA Oncol; 2016 Apr; 2(4):445-52. PubMed ID: 26720497
[TBL] [Abstract][Full Text] [Related]
27. Oral fluoropyrimidine versus intravenous 5-fluorouracil for the treatment of advanced gastric and colorectal cancer: Meta-analysis.
Zhang L; Xing X; Meng F; Wang Y; Zhong D
J Gastroenterol Hepatol; 2018 Jan; 33(1):209-225. PubMed ID: 28608993
[TBL] [Abstract][Full Text] [Related]
28. [Clinical effects of Hange-shashin-to on combination therapy of S-1/irinotecan against the for patients with metastatic gastric and colorectal cancer].
Hibi S; Ina K; Furuta R; Kataoka T; Kojima S; Kawai M
Gan To Kagaku Ryoho; 2009 Sep; 36(9):1485-8. PubMed ID: 19755817
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy for operable and advanced colorectal cancer.
Aschele C; Bergamo F; Lonardi S
Cancer Treat Rev; 2009 Oct; 35(6):509-16. PubMed ID: 19481872
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancer.
Bamias A; Papamichael D; Syrigos K; Pavlidis N
J Chemother; 2003 Jun; 15(3):275-81. PubMed ID: 12868555
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic value of knowledge of cancer on quality of life in advanced colorectal cancer in clinical practice].
Adamowicz K
Wiad Lek; 2016; 69(6):708-713. PubMed ID: 28214800
[TBL] [Abstract][Full Text] [Related]
32. Combination chemotherapy of continuous 5-FU infusion and low-dose cisplatin infusion for the treatment of advanced and recurrent gastric and colorectal adenocarcinomas.
Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():528-34. PubMed ID: 10895205
[TBL] [Abstract][Full Text] [Related]
33. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.
Slevin ML; Stubbs L; Plant HJ; Wilson P; Gregory WM; Armes PJ; Downer SM
BMJ; 1990 Jun; 300(6737):1458-60. PubMed ID: 2379006
[TBL] [Abstract][Full Text] [Related]
34. Examining the effects of adjuvant chemotherapy on cognition and the impact of any cognitive impairment on quality of life in colorectal cancer patients: study protocol.
Dwek MR; Rixon L; Simon A; Hurt C; Newman S
BMC Psychol; 2015 Nov; 3():43. PubMed ID: 26612628
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer.
Hazama S; Watanabe S; Ohashi M; Yagi M; Suzuki M; Matsuda K; Yamamoto T; Suga Y; Suga T; Nakazawa S; Oka M
Anticancer Res; 2009 Jul; 29(7):2611-7. PubMed ID: 19596936
[TBL] [Abstract][Full Text] [Related]
36. Discrepancies in the use of chemotherapy and artificial nutrition near the end of life for hospitalised patients with metastatic gastric or oesophageal cancer. A countrywide, register-based study.
Kempf E; Tournigand C; Rochigneux P; Aubry R; Morin L
Eur J Cancer; 2017 Jul; 79():31-40. PubMed ID: 28458120
[TBL] [Abstract][Full Text] [Related]
37. [Effectiveness of chemotherapy for outpatients with gastric or colorectal cancer].
Gotoh M; Kawabe S; Takiuchi H; Ohta S; Katsu K
Gan To Kagaku Ryoho; 2002 Dec; 29 Suppl 3():470-4. PubMed ID: 12536832
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of Modified FOLFOX in Elderly Patients Aged ≥80 Years with Metastatic Gastric Cancer or Colorectal Cancer.
Lim KH; Lee HY; Park SB; Song SY
Oncology; 2017; 93(2):115-121. PubMed ID: 28445892
[TBL] [Abstract][Full Text] [Related]
39. Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry.
Beijers AJ; Mols F; Tjan-Heijnen VC; Faber CG; van de Poll-Franse LV; Vreugdenhil G
Acta Oncol; 2015 Apr; 54(4):463-9. PubMed ID: 25417732
[TBL] [Abstract][Full Text] [Related]
40. Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study.
Thuss-Patience PC; Shah MA; Ohtsu A; Van Cutsem E; Ajani JA; Castro H; Mansoor W; Chung HC; Bodoky G; Shitara K; Phillips GDL; van der Horst T; Harle-Yge ML; Althaus BL; Kang YK
Lancet Oncol; 2017 May; 18(5):640-653. PubMed ID: 28343975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
